XXVII EFMC International Symposium on Medicinal Chemistry

September 4, 2022 - September 8, 2022
Nice, France
Learn More

The 2022 EFMC-IFMC program will cover advances will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer.

EFMC-ISMC 2022 will also feature most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues. Innovative approaches in medicinal chemistry will be included such as the development of immunomodulating compounds or the application of affinity selection – mass spectrometry for drug discovery.

Join our Team at the Welcome Reception sponsored by WuXi AppTec, and don't forget to visit us in-person at booth #23.

Find our involvement through the scientific program and below:

Introduction to Self-Service DNA-Encoded libraries (DELs)
Nuska Tschammer, Head of DEL, WuXi AppTec

DNA-Encoded library (DEL) screening is now commonly used in the pharmaceutical industry and academia to find novel chemical matter that modulates protein targets of interest.  We will discuss how DELopen and DELight kits work.  DELopen is a freely accessible collection of DELs that can be used for academic drug-discovery.  DELight is a self-service kit that allows pharmaceutical companies to conduct a DEL screen in their own lab, without needing to reveal the identity of their target.
Scientific Posters
The Critical Platforms of Proteolysis Targeting Chimera Validation
Dave Madge, Vice President of Discovery Services, WuXi AppTec
DNA-Encoded Libraries + Machine Learning: New Coming Wave for Hit Discovery
Nuska Tschammer, Head of DEL, WuXi AppTec
Dr. Dave Madge, Vice President of Discovery Services, WuXi AppTec
Dr. Nuska Tschammer, Head of DEL, WuXi AppTec
Dr. Alessandro Spedito, Director Business Development, WuXi AppTec
Dr. Armelle Logié-Dishington, Director Business Development, WuXi AppTec

Meet with Our Team